Vranic Semir

Country: Bosnia and Herzegovina
E-mail: semir.vranic@gmail.com

Participation in Working Groups

  • WG3 - New methodologies to study mechanobiology of cells and tissues

Research Interests

Research focused on molecular mechanisms of human cancers (breast, genitourinary, gynecologic, head & neck, rare cancer subtypes).

The role of immune mechanisms (biomarkers) in cancer progression and treatment (lymphomas, leukemias)

Technologies offered to other EuroCellNet participants


In-situ hybridization


Technologies sought from other EuroCellNet participants


Cytogenetic studies

Cell culturing


1. Vranic S, Tawfik O, Palazzo J, Bilalovic N, Eyzaguirre E, Lee LMJ, Adegboyega P, Hagenkord J, Gatalica Z. EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast. Mod Pathol 2010;23:644-53.

2. Vranic S, Teruya B, Repertinger S, Ulmer P, Hagenkord J, Gatalica Z. Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17. Cancer 2011;117:48-53.

3. Zhang XT, Kang LG, Ding L, Vranic S, Gatalica Z, Wang ZY. A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene 2011;30:770-80.

4. Gatalica Z, Snydder C, Maney T, Ghazalpour A, Holterman DA, Xiao N, Overberg P, Rose I, Basu GD, Vranic S, Lynch HT, Von Hoff DD, Hamid O. Programmed cell death (PD-1) and its ligand (PD-L1) expression in common cancers and their correlation with molecular cancer type. Cancer Epidemiol Biomarkers Prev 2014;23:2965-70.

5. Vranic S, Marchio C, Castellano I, Botta C, Scalzo MS, Bender RP, Payan-Gomez C, Verdun di Cantogno L, Gugliotta P, Tondat F, Francia di Celle P, Mariani S, Gatalica Z, Sapino A. Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast. Hum Pathol 2015;46:1350-9.

6. Vranic S, Ghosh N, Jin J, Kimbrough J, Bilalovic N, Bender R, Arguello D, Veloso Y, Hendershot T, Dizdarevic A, Gatalica Z. PD-L1 status in refractory lymphomas. PLOS One 2016, in press.


News archive